Electrophysiology of Vascular Smooth Muscle

  • Nicholas Sperelakis
Part of the Developments in Cardiovascular Medicine book series (DICM, volume 34)


This chapter provides an overview of the electrophysiology of vascular smooth muscle, and of how the actions of some vasoactive substances are mediated by changes in electrical properties of the cell membrane. Emphasis is given to the role of Ca2+ ion and to the action of inhibitor drugs.


Vascular Smooth Muscle Cardiac Glycoside Coronary Circulation Slow Channel Small Mesenteric Artery 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Mekata F: Electrophysiological properties of the smooth muscle cell membrane of the dog coronary artery. J Physiol (Lond) 298: 205–212, 1980.Google Scholar
  2. 2.
    Somlyo AP, Somlyo AV: Vascular smooth muscle. I. Normal structure, pathology, biochemistry and biophysics. Pharmacol Rev 20: 197–272, 1968.PubMedGoogle Scholar
  3. 3.
    Droogmans G, Raeymaekers L, Casteels R: Electroand pharmacomechanical coupling in the smooth muscle cells of the rabbit ear artery. J Gen Physiol 70: 129–148, 1977.PubMedCrossRefGoogle Scholar
  4. 4.
    Somlyo AV, Somlyo AP: Electromechanical and pharmacomechanical coupling in vascular smooth muscle. J Pharmacol Exp Ther 159: 129–145, 1968.PubMedGoogle Scholar
  5. 5.
    Somlyo AV, Vinall P, Somlyo AP: Excitation-contraction coupling and electrical events in two types of vascular smooth muscle. Microvasc Res 1: 354–373, 1969.PubMedCrossRefGoogle Scholar
  6. 6.
    Johansson B: Electromechanical and mechanoelectrical coupling in vascular smooth muscle. Angiologia 8: 129–143, 1971.Google Scholar
  7. 7.
    Johansson B: Processes involved in vascular smooth muscle contraction and relaxation. Circ Res 43: 1420, 1978.Google Scholar
  8. 8.
    Zelcer E, Sperelakis N: Ionic dependence of electrical activity in small mesenteric arteries of guinea pig. Pflugers Arch 392: 72–78, 1981.PubMedCrossRefGoogle Scholar
  9. 9.
    Harder DR, Sperelakis N: Action potentials induced in guinea pig arterial smooth muscle by tetraethylammonium. Am J Physiol 237: C75–86, 1979.PubMedGoogle Scholar
  10. 10.
    Kumamoto M: Electrophysiological basis for drug action on vascular smooth muscle. In: Carnier O, Shibata S (eds) Factors influencing vascular resistivity. Tokyo: Igaku-Shoin, 1977, pp 106–131.Google Scholar
  11. 11.
    Horn L: Electrophysiology of vascular smooth muscle. In: Kaley G, Altura B (eds) Microcirculation, vol 2. Baltimore: University Park Press, 1978 pp 119–157.Google Scholar
  12. 12.
    Bolton TB: Mechanisms of action of transmitters and other substances on smooth muscle. Physiol Rev 59: 606–718, 1979.PubMedGoogle Scholar
  13. 13.
    Johansson B, Somlyo AP: Electrophysiology and excitation-contraction coupling. In: Bohr DF, Somlyo AP, Sparks HV (eds) Handbook of physiology, Sect 2: The cardiovascular system. Vol 2: Vascular smooth muscle. Bethesda MD: American Physiological Society, 1980, pp 301–323.Google Scholar
  14. 14.
    Harder D, Sperelakis N: Membrane electrical properties of vascular smooth muscle from guinea pig superior mesenteric artery. Pflugers Arch 378: 111–119, 1978.PubMedCrossRefGoogle Scholar
  15. 15.
    Harder D, Belardinelli L, Sperelakis N, Rubio R, Berne RM: Differential effects of adenosine and nitroglycerin on the action potentials of large and small coronary arteries. Circ Res 44: 176–182, 1979.PubMedCrossRefGoogle Scholar
  16. 16.
    Belardinelli L, Harder D, Sperelakis N, Rubio R, Berne RM: Cardiac glycoside stimulation of inward Ca+ + current in vascular smooth muscle of canine coronary artery. J Pharmacol Exp Ther 209: 62–66, 1979.PubMedGoogle Scholar
  17. 17.
    Sperelakis N: Origin of the cardiac resting potential. In Berne RM, Sperelakis N (eds) Handbook of physiology Sect 2: The cardiovascular system. Vol 1: The heart. Bethesda MD: American Physiological Society, 1979, pp 187–267.Google Scholar
  18. 18.
    Sperelakis N, Schneider MF, Harris EJ: Decreased K+ conductance produced by Ba++ in frog sartorius fibers. J Gen Physiol 50: 1565–1583, 1967.PubMedCrossRefGoogle Scholar
  19. 19.
    Sperelakis N, Lehmkuhl D: Effect of current on transmembrane potential in cultured chick heart cells. J Gen Physiol 47: 895–927, 1964.PubMedCrossRefGoogle Scholar
  20. 20.
    Sperelakis N: Propagation mechanisms in heart. Annu Rev Physiol 41: 441–457, 1979.PubMedCrossRefGoogle Scholar
  21. 21.
    Tomita T: Electrical responses of smooth muscle to external stimulation in hypertonic solution. J Physiol (Load) 183: 450–468, 1966.Google Scholar
  22. 22.
    Harder DR: Membrane electrical effects of histamine on vascular smooth muscle of canine coronary artery. Circ Res 46: 372–377, 1980.PubMedCrossRefGoogle Scholar
  23. 23.
    Bonaccorsi A, Hermsmeyer K, Aprigliano O, Smith CP, Bohr DF: Mechanism of potassium relaxation of arterial muscle. Blood Vessels 14: 261–276, 1977.PubMedGoogle Scholar
  24. 24.
    Haddy FJ: The mechanism of potassium vasodilation. In: Vanhoutte PM, Leusen I (eds) Mechanisms of vasodilation. Basel: Karger, 1978, pp 200–205.Google Scholar
  25. 25.
    Webb RC, Bohr DF: Potassium-induced relaxation as an indicator of Na+-K+ ATPase activity in vascular smooth muscle. Blood Vessels 15: 198–207, 1978.PubMedGoogle Scholar
  26. 26.
    Webb RC, Bohr DF: Potassium relaxation of vascular smooth muscle from spontaneously hypertensive rats. Blood Vessels 16: 71–79, 1979.PubMedGoogle Scholar
  27. 27.
    Casteels R, Kitamura K, Kuriyama H, Suzuki H: The membrane properties of the smooth muscle cells of rabbit pulmonary artery. J Physiol 271: 41–61, 1977.PubMedGoogle Scholar
  28. 28.
    Haeusler G: Relationship between noradrenaline-induced depolarization and contraction in vascular smooth muscle. Blood Vessels 15: 46–54, 1978.PubMedGoogle Scholar
  29. 29.
    Ito Y, Suzuki H, Kuriyama H: Effects of sodium nitroprusside on smooth muscle cells of rabbit pulmonary artery and portal vein. J Pharmacol Exp Ther 207: 1022–1031, 1978.PubMedGoogle Scholar
  30. 30.
    Mekata F, Niu H: Biophysical effects of adrenaline on the smooth muscle of the rabbit common carotid artery. J Gen Physiol 59: 92–102, 1972.PubMedCrossRefGoogle Scholar
  31. 31.
    Kuriyama H, Suzuki H: Electrical property and chemical sensitivity of vascular smooth muscles in normotensive and spontaneously hypertensive rats. J Physiol (Lond) 285: 409–424, 1978.Google Scholar
  32. 32.
    Zelcer E, Sperelakis N: Spontaneous electrical activity in pressurized small mesenteric arteries. Blood Vessels 19: 301–310, 1982.PubMedGoogle Scholar
  33. 33.
    Mekata F: Electrophysiological studies of the smooth muscle cell membrane of rabbit common cartotid artery. J Gen Physiol 57: 738–751, 1971.PubMedCrossRefGoogle Scholar
  34. 34.
    Holman ME, Surprenant AM: Some properties of the excitatory junction potentials recorded from saphenous arteries of rabbits. J Physiol 287: 337–351, 1979.PubMedGoogle Scholar
  35. 35.
    Harder DR: Membrane electrical activation of arterial smooth muscle. In Crass C, Barnes CD (eds) Research topics in physiology: vascular smooth muscle. New York: Academic, 1981, pp 71–97.Google Scholar
  36. 36.
    Kohlhardt M, Fleckenstein A: Inhibition of the slow inward current by nifedipine in mammalian ventricular myocardium. Naunyn Schmiedebergs Arch Pharmacol 298: 267–272, 1977.PubMedCrossRefGoogle Scholar
  37. 37.
    Shigenobu K, Schneider JA, Sperelakis N: Verapamil blockade of slow NA+ and Ca+ + responses in myocardial cells. J Pharmacol Exp Ther 190: 280–288, 1974.PubMedGoogle Scholar
  38. 38.
    Vogel S, Crampton R, Sperelakis N: Blockade of myocardial slow channels by bepridil (CERM-1978). J Pharmacol Exp Ther 210: 378–385, 1979.PubMedGoogle Scholar
  39. 39.
    Harder DR, Sperelakis N: Action potential generation in reaggregates of rat aortic smooth muscle cells in primary culture. Blood Vessels 16: 186–201, 1979.PubMedGoogle Scholar
  40. 40.
    Harder DR, Sperelakis N: Bepridil blockade of Ca++-dependent action potentials in vascular smooth muscle of dog coronary artery. J Cardiovasc Pharmacol 3: 906–914, 1981.PubMedCrossRefGoogle Scholar
  41. 41.
    Mras S, Sperelakis N: Bepridil (CERM-1978) blockade of action potentials in cultured rat aortic smooth cells. Eur J Pharmacol 71: 13–19, 1981.PubMedCrossRefGoogle Scholar
  42. 42.
    Mras S, Sperelakis N: Bepridil (CERM-1978) and verapamil depression of contractions of rabbit aortic rings. Blood Vessels 18: 196–205, 1981.PubMedGoogle Scholar
  43. 43.
    Sperelakis N, Mras S: Depression of contractions of rabbit aorta and guinea pig vena cava by mesudipine and slow channel blockers. Blood Vessels, 1983 (in press).Google Scholar
  44. 44.
    Fabiato A, Fabiato F: Calcium and cardiac excitation-contraction coupling. Annu Rev Physiol 41: 473–484, 1979.PubMedCrossRefGoogle Scholar
  45. 45.
    Ridgway EB, Gordon AM, Martyn DA: Hysteresis in the force-calcium relation in muscle. Science 219: 1075–1077, 1983.PubMedCrossRefGoogle Scholar
  46. 46.
    Casteels R: Electro-and pharmacomechanical coupling in vascular smooth muscle. Chest (Suppl) 78: 150–156, 1980.Google Scholar
  47. 47.
    Van Breeman C, Aaronson T, Loutzenhifer R: Sodium-calcium interactions in mammalian smooth muscle. Pharmacol Rev 30: 167–208, 1979.Google Scholar
  48. 48.
    Motulsky HJ, Snavely MD, Hughes RJ, Insel PA: Interaction of verapamil and other calcium channel blockers with a,- and a2-adrenergic receptors. Circ Res 52: 226–231, 1983.PubMedCrossRefGoogle Scholar
  49. 49.
    Fleckenstein A, Nakayama K, Fleckenstein-Grün G, Byon YK: Interactions of vasoactive ions and drugs with Ca-dependent excitation-contraction coupling of vascular smooth muscle. In Carafoli E (ed) Calcium transport in contraction and secretion. Amsterdam: North Holland, 1975, pp 555–564.Google Scholar
  50. 50.
    Schnaar RC, Sparks HV: Response of large and small coronary arteries in nitroglycerin, NaNO2 and adenosine. Am J Physiol 223: 223–228, 1972.PubMedGoogle Scholar
  51. 51.
    Kohlhardt M, Bauer B, Krause H, Fleckenstein A: Differentiation of the transmembrane Na and Ca channels in mammalian cardiac fibers by the use of specific inhibitors. Pflugers Arch 335: 309–322, 1972.PubMedCrossRefGoogle Scholar
  52. 52.
    Fleckenstein A: Specific pharmacology of calcium in myocardium, cardiac pacemaker and vascular smooth muscle. Annu Rev Pharmacol Toxicol 17: 149–166, 1977.PubMedCrossRefGoogle Scholar
  53. 53.
    McLean MJ, Shigenobu K, Sperelakis N: Two pharmacological types of cardiac slow Na+ channels as distinguished by verapamil. Eur J Pharmacol 26: 379–382, 1974.PubMedCrossRefGoogle Scholar
  54. 54.
    Labrid C, Grosset A, Dureng G, Mironneau J, Duchene-Marullaz P: Some membrane interactions with bepridil, a new antianginal agent. J Pharmacol Exp Ther 211: 546–554, 1979.PubMedGoogle Scholar
  55. 55.
    Peiper U, Griebel L, Wende W: Activation of vascular smooth muscle of rat aorta by noradrenaline and depolarization: two different mechanisms. Pflug-ers Arch 330: 74–89, 1971.CrossRefGoogle Scholar
  56. 56.
    Haeusler G: Differential effect of verapamil on excitation-contraction coupling in smooth muscle and on excitation-secretion coupling in adrenergic nerve terminals. J Pharmacol Exp Ther 180: 672–682, 1972.PubMedGoogle Scholar
  57. 57.
    Massingham R: A study of compounds which inhibit vascular smooth muscle contraction. Eur J Pharmacol 22: 75–82, 1973.PubMedCrossRefGoogle Scholar
  58. 58.
    Bilek I, Laven R, Peiper R, Regnat K: The effect of verapamil on the response to noradrenaline or to potassium-depolarization in isolated vascular strips. Microvasc Res 7: 181–189, 1974.PubMedCrossRefGoogle Scholar
  59. 59.
    Golenhofen K: Theory of P and T systems for calcium activation in smooth muscle. In: Bulbring F, Shuba MF (eds) Physiology of smooth muscle. New York: Raven, 1976, pp 197–202.Google Scholar
  60. 60.
    Cosnier D, Duchene-Marullaz P, Rispat G, Streichenberger G: Cardiovascular pharmacology of bepridil (1-[3-Isobutoxy-2-(benzyl-phenyl) amino) propyl pyrrolidine hydrochloride): a new potential anti-anginal compound. Arch Int Pharacodyn Ther 225: 131–151, 1977.Google Scholar
  61. 61.
    Michelin FT, Cheucle M, Duchene-Marullaz P: Comparative influence of bepridil, dipyridimole and propranolol on cardiac activity and coronary venous blood flow in the anesthetized dog. Therapie 32: 485–490, 1977.PubMedGoogle Scholar
  62. 62.
    Romano JP, Jouve A: Utilization clinique d’un nouvel anti-angineaux, le 1978 CERM (Bepridil, RL). Vie Med 1: 1789–1791, 1978.Google Scholar
  63. 63.
    Schneider JA, Sperelakis N: Slow Ca++ and Na+ responses induced by isoproterenol and methylxanthines in isolated perfused guinea pig hearts exposed to elevated K. J Mol Cell Cardiol 7: 249–273, 1975.PubMedCrossRefGoogle Scholar
  64. 64.
    Sperelakis N: Electrophysiology of vascular smooth muscle of coronary artery. In: Kalsner S (ed) The coronary artery. London: Croom Helm, 1982, pp 118–167.Google Scholar
  65. 65.
    Josephson I, Sperelakis N: Ouabain blockade of inward slow current in cardiac muscle. J Mol Cell Cardiol 9: 409–418, 1977.PubMedCrossRefGoogle Scholar
  66. 66.
    Casteels R, Suzuki H. The effect of histamine on the smooth muscle cells of the ear artery of the rabbit. Pflugers Arch 387: 17–25, 1980.PubMedCrossRefGoogle Scholar
  67. 67.
    Hirst GDS: Neuromuscular transmission in arterioles of guinea-pig submucosa. J Physiol 273: 263–275, 1977.PubMedGoogle Scholar
  68. 68.
    Hirst GDS, Neild TO: An analysis of excitatory junctional potentials recorded from arterioles. J Physiol 280: 87–104, 1978.PubMedGoogle Scholar
  69. 69.
    Hirst GDS, Neild TO: Some properties of spontaneous excitatory junction potentials recorded from arterioles of guinea-pigs. J Physiol 303: 43–60, 1980.PubMedGoogle Scholar
  70. 70.
    Hirst GDS, Neild TO: Evidence for two populations of excitatory receptors for noradrenaline on arteriolar smooth muscle. Nature 283: 767–768, 1980.PubMedCrossRefGoogle Scholar
  71. 71.
    Hirst GDS, Neild TO: Localization of specialized noradrenaline receptors at neuromuscular junctions on arterioles of the guinea-pig. J Physiol 313: 343350, 1981.Google Scholar
  72. 72.
    Holman ME, Surprenant AM: Effects of tetraethylammonium chloride on sympathetic neuromuscular transmission in saphenous artery of young rabbits. J Physiol 305: 451–465, 1980.PubMedGoogle Scholar
  73. 73.
    Holman ME, Surprenant AM: An electrophysiological analysis of the effects of noradrenaline and a-receptor antagonists on neuromuscular transmission in mammalian muscular arteries. Br J Pharmacol 71: 651–661, 1980.PubMedCrossRefGoogle Scholar
  74. 74.
    Surprenant A: A comparative study of neuromuscular transmission in several mammalian muscular arteries. Pflugers Arch 386: 85–91, 1980.PubMedCrossRefGoogle Scholar
  75. 75.
    Ross R, Glomset J, Kariya B, Harker L: A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro. Proc Natl Acad Sci USA 71: 1207–1210, 1974.PubMedCrossRefGoogle Scholar
  76. 76.
    Sperelakis N: Cultured heart cell reaggregate model for studying problems in cardiac toxicology. In: Van Stee EW (ed) Cardiovascular toxicology. New York: Raven, 1982, pp 57–108.Google Scholar
  77. 77.
    Chamley J II, Campbell GR: Mitosis of contractile smooth muscle cells in tissue culture. Exp Cell Res 84: 105–110, 1974.PubMedCrossRefGoogle Scholar
  78. 78.
    Hermsmeyer K, De Cino P, White R: Spontaneous contractions of dispersed vascular smooth muscle in cell culture in vitro 12: 628–634, 1976.Google Scholar
  79. 79.
    McLean MJ, Sperelakis N: Electrophysiological recordings from spontaneously contracting reaggregates of cultured vascular smooth muscle cells from chick embryos. Exp Cell Res 104: 309–318, 1977.PubMedCrossRefGoogle Scholar
  80. 80.
    Hermsmeyer K: High shortening velocity of isolated single arterial muscle cells. Experientia 35: 1599–1602, 1979.PubMedCrossRefGoogle Scholar
  81. 81.
    Zelcer E, Sperelakis N: Angiotensin induction of active responses in cultured reaggregates of rat aortic smooth muscle cells. Blood Vessels 18: 263–279, 1981.PubMedGoogle Scholar
  82. 82.
    Kimes BW, Brandt BL: Characterization of two putative smooth muscle cell lines from rat thoracic aorta. Exp Cell Res 98: 349–366, 1976.PubMedCrossRefGoogle Scholar
  83. 83.
    McLean MJ, Pelleg A, Sperelakis N: Electrophysiological recordings from spontaneously contracting reaggregates of cultured vascular smooth muscle cells from guinea pig vas deferens. J Cell Biol 890: 439–452, 1979.Google Scholar
  84. 84.
    Johns DW, Sperelakis N: Angiotensin-II depolarization of cultured vascular smooth muscle cells [abstr 8151. Circulation (Suppl 2 ) 66: 111–204, 1982.Google Scholar
  85. 85.
    Biamino E, Kruckenberg P: Synchronization and conduction of excitation in the rat aorta. Am J Physiol 217: 276–282, 1969.Google Scholar
  86. 86.
    Sperelakis N: Changes in membrane electrical properties during development of the heart. In: Zipes DP, Bailey JC, Elharrar V (eds) The slow inward current and cardiac arrhythmias. The Hague: Martinus Nijhoff, 1980, pp 221–262.CrossRefGoogle Scholar
  87. 87.
    Berne RM: Cardiac nucleotides in hypoxia: possible role in regulation of coronary blood flow. Annu J Physiol 204: 317–322, 1963.Google Scholar
  88. 88.
    Hescheler J, Pelzer D, Trube G, Trautwein W: Does the organic calcium channel blocker D600 act from inside or outside on the cardiac cell membrane? Pflugers Arch 393: 287–291, 1982.PubMedCrossRefGoogle Scholar
  89. 89.
    Mras S, Sperelakis N: Comparison of 3H-bepridil and 3H-verapamil uptake into rabbit aortic rings. J Cardiovasc Pharmacol 4: 777–783, 1982.PubMedCrossRefGoogle Scholar
  90. 90.
    Pang DC, Sperelakis N: Nifedipine, diltiazem, bepridil and verapamil uptakes into cardiac and smooth muscles. Eur J Pharmacol 87: 199–207, 1983.PubMedCrossRefGoogle Scholar
  91. 91.
    Pang DC, Sperelakis N: Uptakes of calcium antagonists into muscles as related to their lipid solubilities. Biochem Pharmacol 1983 (in press).Google Scholar
  92. 92.
    Pang DC, Sperelakis N: Inhibitory action of bepridil (CERM-1978) on calcium binding to cardiac sarcolemma of guinea pig. Biochem Pharmacol 30: 2356–2358, 1981.PubMedCrossRefGoogle Scholar
  93. 93.
    Pang DC, Sperelakis N: Differential actions of calcium antagonists on calcium binding to cardiac sarcolemma. Eur J Pharmacol 81: 403–409, 1982.PubMedCrossRefGoogle Scholar
  94. 94.
    Forbes MS, Sperelakis N: Bridging junctional processes in couplings of skeletal, cardiac, and smooth muscle. Muscle Nerve 5: 674–681. 1982.CrossRefGoogle Scholar
  95. 95.
    Thakkar JK, Sperelakis N, Pang D, Franson RC: Characterization of phospholipase A2 activity in rat aorta smooth muscle cells. Biochim Biophys Acta 750: 134–140, 1983.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 1984

Authors and Affiliations

  • Nicholas Sperelakis

There are no affiliations available

Personalised recommendations